Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Sponsor: Q32 Bio Inc.
Summary
Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. Part B is a multicenter, open-label study to assess the efficacy, safety, and tolerability of bempikibart (ADX-914) in participants with severe Alopecia Areata.
Official title: A Phase 2a, Randomized, Double-blind, Placebo-Controlled, Proof-of-Concept Trial With Part B and Open-label Extension of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2023-09-12
Completion Date
2026-09
Last Updated
2025-10-31
Healthy Volunteers
No
Conditions
Interventions
bempikibart (ADX-914)
Subcutaneous administration of bempikibart (ADX-914)
Locations (33)
Scottsdale, Arizona
Scottsdale, Arizona, United States
Fayetteville, Arkansas
Fayetteville, Arkansas, United States
Hot Springs, Arkansas
Hot Springs, Arkansas, United States
Encinitas, California
Encinitas, California, United States
Fountain Valley, California
Fountain Valley, California, United States
Lomita, California
Lomita, California, United States
New Haven, Connecticut
New Haven, Connecticut, United States
Miami, Florida
Miami, Florida, United States
Tampa, Florida
Tampa, Florida, United States
Clarksville, Indiana
Clarksville, Indiana, United States
Bowling Green, Kentucky
Bowling Green, Kentucky, United States
Burlington, Massachusetts
Burlington, Massachusetts, United States
Troy, Michigan
Troy, Michigan, United States
Warren, Michigan
Warren, Michigan, United States
New York, New York
New York, New York, United States
New York, New York
New York, New York, United States
Wilmington, North Carolina
Wilmington, North Carolina, United States
Bexley, Ohio
Bexley, Ohio, United States
Clinical Trials
Canton, Ohio, United States
Mason, Ohio
Mason, Ohio, United States
Mayfield Heights, Ohio
Mayfield Heights, Ohio, United States
Portland, Oregon
Portland, Oregon, United States
Austin, Texas
Austin, Texas, United States
Frisco, Texas
Frisco, Texas, United States
Houston, Texas
Houston, Texas, United States
San Antonio, Texas
San Antonio, Texas, United States
Jordan, Utah
Jordan, Utah, United States
Spokane, Washington
Spokane, Washington, United States
Clinical Trials
Calgary, Alberta, Canada
Clinical Trials
Winnipeg, Manitoba, Canada
Clinical Trials
Oakville, Ontario, Canada
Clinical Trials
Peterborough, Ontario, Canada
Clinical Trials
Waterloo, Ontario, Canada